RSCM
VINC

Rock Springs Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Rock Springs Capital Management’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-44,586
Closed -$234K – 112
2024
Q4 		$234K Hold
44,586
– – 0.01% 105
2024
Q3 		$638K Hold
44,586
– – 0.02% 105
2024
Q2 		$722K Hold
44,586
– – 0.02% 109
2024
Q1 		$4.51M Hold
44,586
– – 0.11% 94
2023
Q4 		$1.05M Hold
44,586
– – 0.03% 100
2023
Q3 		$901K Hold
44,586
– – 0.02% 109
2023
Q2 		$1.16M Hold
44,586
– – 0.03% 114
2023
Q1 		$927K Hold
44,586
– – 0.02% 115
2022
Q4 		$910K Sell
44,586
-10,843
-20% -$204K 0.02% 114
2022
Q3 		$1.53M Buy
55,429
+14,719
+36% +$423K 0.04% 116
2022
Q2 		$1.07M Hold
40,710
– – 0.03% 125
2022
Q1 		$3.26M Buy
40,710
+250
+0.6% +$30.9K 0.08% 118
2021
Q4 		$8.25M Buy
40,460
+445
+1% +$111K 0.19% 99
2021
Q3 		$12.9M Buy
+40,015
New +$11.7M 0.27% 93

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return